City

Houston (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

M.D. Anderson Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

bortezomib (1)

clofarabine (1)

cyclophosphamide (1)

dexamethasone (1)

etoposide (1)

ofatumumab (1)

pegfilgrastim (1)

rituximab (1)

vincristine sulfate liposome (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

recurrent burkitt leukemia

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston

Recruiting

Recurrent Acute Lymphoblastic Leukemia
+10 more

Bortezomib
+8 more

Houston, Texas

M D Anderson Cancer Center

Sep 21, 2022